Improved NK cell activation had been reported with dual CD16a/NKp46 engagement compared to single CD16a or NKp46 targeting agents or combination of these molecules [126], and cytotoxic activity was only induced in the presence of MM cells and associated with low cytokine release. The gene discussed is FCGR3A; the disease is Miyoshi myopathy.